Grifols + CAPriCORN Collaboration on Convalescent Plasma Donation

If you recovered from COVID-19, your blood contains hyperimmune globulin, a blood protein that can help others fight COVID-19. Participate in our study to contribute to the development of possible COVID-19 therapies. 

Purpose of the Study

• The purpose of this study is to make COVID-19 recovered individuals aware of the ability to donate plasma to create a product that will support a future clinical trial using hyperimmune globulin, and to connect you with a Grifols donation center.
• You will be asked to schedule and complete two plasma donation appointments with Grifols at a donation site.
• The primary potential risk of participation is possibly feeling uncomfortable with the reason you are being contact (recovered form COVID-19) or with some of the questions you may be asked regarding disease statuses or IV drug use.
• The main benefit of being in this study is the potential for results from the plasma donation

Participation Eligibility & Requirements

You must meet all of the following criteria to participate in this study:

• You have recovered from COVID-19 and have been symptom free for at least 14 days.
• You are between the ages of 18 and 69.
• You weigh more than 110lbs.
• You have no history of diabetes, heart disease, autoimmune disease, severe chronic conditions or cancer in the last 5 years.
• You have no history of HIV, hepatitis, or IV drug use.

Once approved to participate in the study:

1. Someone from our team will help you connect with a Grifols donation center nearest to you and schedule an appointment in the near future.
2. Should you need it, Grifols schedulers can work with you to arrange transportation to and from the donation center.
3. You may receive several follow-up calls from our team to check-in on you before or up to 4 weeks after your scheduled donation time.

Compensation

Participants will receive up to $180 per donation directly from Grifols at the time of donation. Grifols will also provide compensation for transportation to and from the donation center, as well as COVID-19 testing vouchers to share with family and friends to allow them to be tested.

Contact the Study Team to Participate

Principal Investigator

• Abel Kho, MD, MS

Collaborating Institutions & Organizations

CAPriCORN Sites:

• Cook County Health
• Northwestern University
• Rush University Medical Center
• University of Illinois at Chicago

Sponsor

• Grifols

Contact

If you have questions, concerns, or complaints, you can contact the overall Principal Investigator for this study: Abel Kho, MD MS, Feinberg School of Medicine, Institute for Public Health and Medicine, Center for Health Information Partnerships, 312-503-6460, a-kho@northwestern.edu.

IRB Information

This study has been reviewed and approved by an Institutional Review Board (“IRB”) – an IRB is a committee that protects the rights of people who participate in research studies. You may contact the IRB for this study (Chicago Area IRB, CHAIRb, University of Illinois at Chicago Office for the Protection of Research Subjects, OPRS) by phone at 312-996-1711 or 866-789-6215 (toll free) or by e-mail at uicirb@uic.edu if:

• Your questions, concerns, or complaints are not being answered by the research team.
• You cannot reach the research team.
• You want to talk to someone besides the research team.
• You have questions about your rights as a research participant.
• You want to get information or provide input about this research.

Learn more about convalescent plasma donation at thefightisinus.org.